Quick10K

⚲

Brighthouse Life Insurance

Filings

10-Q	2020-09-30	Filed 2020-11-09
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-12
10-K	2019-12-31	Filed 2020-03-05
10-Q	2019-09-30	Filed 2019-11-06
10-Q	2019-06-30	Filed 2019-08-07
10-Q	2019-03-31	Filed 2019-05-08
10-K	2018-12-31	Filed 2019-03-05
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-10
10-K	2017-12-31	Filed 2018-03-22
10-Q	2017-09-30	Filed 2017-11-13
10-Q	2017-06-30	Filed 2017-08-11
10-Q	2017-03-31	Filed 2017-05-11
10-K	2016-12-31	Filed 2017-03-28
10-Q	2016-09-30	Filed 2016-11-09
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-12
10-K	2015-12-31	Filed 2016-03-25
10-Q	2015-09-30	Filed 2015-11-12
10-Q	2015-06-30	Filed 2015-08-12
10-Q	2015-03-31	Filed 2015-05-13
10-K	2014-12-31	Filed 2015-03-30
10-Q	2014-09-30	Filed 2014-11-12
10-Q	2014-06-30	Filed 2014-08-13
10-Q	2014-03-31	Filed 2014-05-14
10-K	2013-12-31	Filed 2014-03-31
10-Q	2013-09-30	Filed 2013-11-13
10-Q	2013-06-30	Filed 2013-08-12
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-03-22
10-Q	2012-09-30	Filed 2012-11-13
10-Q	2012-06-30	Filed 2012-08-10
10-Q	2012-03-31	Filed 2012-05-10
10-K	2011-12-31	Filed 2012-03-22
10-Q	2011-09-30	Filed 2011-11-10
10-Q	2011-06-30	Filed 2011-08-12
10-Q	2011-03-31	Filed 2011-05-12
10-K	2010-12-31	Filed 2011-03-23
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-08-13
10-Q	2010-03-31	Filed 2010-05-12
10-K	2009-12-31	Filed 2010-03-24

Reports

8-K

2019-02-05

Brighthouse Life Insurance Financials

BHL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-12-31	2014-03-31	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	1,220	964	745	1,263	968	1,316	895	1,276	746	1,843	1,206	827	731	782	1,383	1,472	2,298	2,117	1,888	2,129	2,233	1,388	1,363	1,411	1,717	1,633	3,494	3,144	3,427	3,720
Accounts Receivable
Inventory
PP&E	519	528	503	500	482	540	708	729
Assets	165,482	163,771	171,771	179,092	176,694	183,659	184,796	190,434	188,039	190,664	205,863	212,322	207,522	203,176	202,362	209,173	214,837	215,407	199,273	200,016	210,663	210,940	212,045	207,226	204,579	204,968	195,830	205,026	209,908	214,847
Accounts Payable
Long-Term Debt	7,410	3,950	3,857	3,738	3,641	3,582	3,350	3,083	2,251	1,790	928	921	911	849	836	826	817	808	804	801	53	50	46	43	40	237	434	845	845	845
Liabilities	156,913	153,379	161,598	169,517	166,409	173,017	174,047	179,634	179,251	181,304	193,857	199,737	196,144	191,383	190,799	194,988	202,075	203,330	189,556	190,171	194,984	194,963	195,177	191,163	188,824	189,767	179,039	188,049	191,553	195,025
Stockholders' Equity	8,569	10,392	10,173	9,575	10,285	10,642	10,749	10,800	8,788	9,360	12,006	12,585	11,378	11,793	11,563	14,185	12,762	12,077	9,717	9,845	15,664	15,962	16,853	16,048	15,740	15,186	16,776	16,962	18,340	19,807


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-12-31	2014-03-31	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	2,167	2,685	2,338	1,504	2,415	1,574	2,624	1,781		1,236		1,883	1,761	1,595	1,865	1,636	-1,260	1,307	-503	802	1,781	1,694	1,414	1,624	1,510	1,238		477	2,112	2,901
Cost of Revenue
Gross Profit
R&D
SG&A
Tax	100	251	-68	0	227	1	353	230		2		103	132	-30	10	31	-886	-150	-766	1	21	567	-719	0	2	1		-1	76	99
Net Income	216	545	319	19	498	-4	710	465																				-754	363	609


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-12-31	2014-03-31	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			390	397	473	587	1,025	460		616		825	773	918	1,689	493	1,592	459	745	437	1,177	821	1,511	409	930	621		523	558	562
Cash Investing		-432	431	1,165	-2,616	-651	955	-1,159		260		-2,760	-568	-2,298	-61	-1,797	-2,292	-836	7,457	-291	-1,608	9	-1,793	-882	-1,143	-1,436		-1,021	-1,643	-2,845
Cash Financing		30	-1,036	-1,048	1,850	408	-2,404	1,096		220		1,555	-299	1,432	-1,027	1,393	1,526	196	-8,431	95	-2,634	-1,675	257	521	519	731		148	1,368	2,576